Cannabis as Cancer
According to many
studies in mice and rats it seems that
cannabinoids may have an
anticancer effects against several types
of cancers. During a 2-year
study, several mice and rats were treated by different doses
of THC by gavage. A considerable
decrease in the incidence
of liver cancer
and adenoma hepatocellular carcinoma
(HCC) were observed among those rats
and mice. The cannabis works
not only against malignant
tumors but also against non-cancerous tumors (benign
tumors) in different
organs such as mammary gland, uterus,
pituitary, testis and
In other various medical
studies, delta-9-THC, delta-8-THC and cannabinol (also an active component found
in Cannabis sativa and Cannabis
indica (both strains are commonly known as
medical marijuana) were shown to reduce the
growth of lewis lung carcinoma cells in vitro
and in vivo. In addition, many other types of
tumors have proven to
be sensitive to the inhibition of growth induced by
cannabinoids. As some people say, it seems
cannabis may work to effectively fight all types of cancer and some other medical conditions considered as
incurable by the medical elite.
When it comes to fight cancer, it is shown
that cannabinoids perform its anti-tumor effects of various
mechanisms, including the induction of cell
death, inhibition of cell
growth, and inhibition
of tumor invasion and angiogenesis metastasis, without causing side effects like the conventional
therapies: radiation therapy
and chemotherapy for instance. The mode of action of
cannabinoids is to kill
tumor cells without
affecting their non-transformed counterparts and may even protect them
Cannabinoids is also an effective pain
killer through its anti-inflammatory mechanism. It does so by acting on mast cell receptors to attenuate
the release of inflammatory agents (histamine and serotonin), and on keratinocytes in order to enhance the
release of analgesic opioids. In fact, the pain killing effect of marijuana is so effective that a
recent study has indicated that the efficacy of synthetic CB1- and CB2-receptor agonists were comparable with
the efficacy of morphine in a murine model of tumor pain. Wow!
Although there are numerous studies still going on, all over the internet (including on
Youtube) individuals continue claiming their success in curing diseases that made their life a living hell
before using medical marijuana. The way it seems to be more effective is by using in concentrate
oil form (Rick Simpson Protocol). Rick Simpson is considered as the father of this
method. Go on Youtube
and type Rick Sympson Cannabis Oil for more
Martin BR: Cannabis: pharmacology and toxicology in animals and humans. Addiction 91 (11): 1585-614,
F, Russo E, eds.: Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential. Binghamton,
NY: The Haworth Press, 2002.
Toxicology Program: NTP toxicology and carcinogenesis studies of 1-trans-delta(9)-tetrahydrocannabinol (CAS No.
1972-08-3) in F344 rats and B6C3F1 mice (gavage studies). Natl Toxicol Program Tech Rep Ser 446 (): 1-317,
Laezza C, Pisanti S, et al.: Cannabinoids and cancer: pros and cons of an antitumour strategy. Br J Pharmacol
148 (2): 123-35, 2006.
de Ceballos ML, Gomez del Pulgar T, et al.: Inhibition of glioma growth in vivo by selective activation of the
CB(2) cannabinoid receptor. Cancer Res 61 (15): 5784-9, 2001.
RJ, Lombard C, Fisher M, et al.: Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant
lymphoblastic disease. Blood 100 (2): 627-34, 2002.
ML, Blázquez C, Martínez-Palacio J, et al.: Inhibition of skin tumor growth and angiogenesis in vivo by
activation of cannabinoid receptors. J Clin Invest 111 (1): 43-50, 2003.
C, González-Feria L, Alvarez L, et al.: Cannabinoids inhibit the vascular endothelial growth factor pathway in
gliomas. Cancer Res 64 (16): 5617-23, 2004.
Cannabinoids: potential anticancer agents. Nat Rev Cancer 3 (10): 745-55, 2003.
C, Casanova ML, Planas A, et al.: Inhibition of tumor angiogenesis by cannabinoids. FASEB J 17 (3): 529-31,